ArticleBioorganic & medicinal chemistry letters2025

Optimization of IRAK1/4/pan-FLT3 kinase inhibitors as treatments for acute myeloid leukemia.

Patrick J Sutter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.